Options Movement At Alnylam Pharmaceuticals: Yvonne Greenstreet Exercises Worth $1.72M

The latest update on Tuesday morning shows Alnylam Pharmaceuticals shares up by 3.84%, trading at $472.0. At this price, ...
Nature

Activation and signaling of the p38 MAP kinase pathway

Cellular behavior in response to extracellular stimuli is mediated through intracellular signaling pathways such as the mitogen-activated protein (MAP) kinase pathways 1. MAP kinases are members of ...
FierceBiotech

UPDATED: Prasad, Makary unveil new FDA path for accelerating custom gene editing therapies

In a highly anticipated article, FDA officials Vinay Prasad, M.D., and Martin Makary, M.D., outlined a novel regulatory pathway that could trigger a seismic shift in how bespoke gene editing therapies ...

Alnylam Pharmaceuticals Announces Changes to Board of Directors

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced changes to its Board of Directors, including the departure of two directors and the appointment of ...
Nature

The LKB1–AMPK pathway: metabolism and growth control in tumour suppression

The serine–threonine liver kinase B1 (LKB1) is inactivated in Peutz–Jeghers syndrome and a large percentage of sporadic non-small cell lung carcinomas and cervical carcinomas. LKB1 acts a master ...
pharmaphorum

Novartis raises mid-term sales outlook on pipeline promise

Novartis said this morning that its pipeline includes more than 30 high-value projects that allow it to achieve sales growth of 6% or more between out to 2029, a point higher than its earlier guidance ...
Oregonian

Dear Doctor: High lipoprotein(a) levels alone aren’t enough to consider patient high risk of heart disease

DEAR DR. ROACH: I’m a healthy 50-year-old woman. I asked my doctor to test me for Lipoprotein(a) after reading about it. My level was high, at 41 mg/dL. My doctor told me that it didn’t need to be ...